QON TOMIR DEMENSIYASI RIVOJLANISHINING XAVF OMILLARI
##article.subject##:
qon tomir demensiyasi, o’rtacha kognitiv buzilishlar##article.abstract##
Qon tomir demensiyasi muhim tibbiy-ijtimoiy muammolardan biri hisoblanadi. Qon tomir demensiyasi rivojlanishining xavf omillarini o’rganish maqsadida 55 yoshdan 80 yoshgachabo’lgan qon tomir demensiyasi bo’lgan 45 ta bemorda klinik-neyrovizualizatsion tekshiruv o’tkazildi. Nazorat guruhini Dissirkulator ensefalopatiya II bosqichi fonidagi o’rtacha kognitiv buzilish (O’KB) li 31 ta bemor tashkil etdi. Qon tomir demensiyasi rivojlanishining prognostik jihatdan muhim xavf omillari 50-59 yoshdaglarda yurak ishemik kasalligi (YIK) va giperlipidemiya, 60-69 yoshda YIK va qandli diabet, 70-79 yoshda giperlipidemiya ekanligini ko’rsatdi. Neyrovizualizatsion tekshiruvlar O’KB li bemorlarda demensiya rivojlanishi bilan miyaning oq moddasida diffuz o'zgarishlarning lokalizatsiyasi va tarqalishi o'rtasidagi bog'liqlikni ko'rsatdi.
Библиографические ссылки
Rakhimbaev G.S., Tolibov D.S. Prevalence and risk factors for the development of Alzheimer's type dementia. Vestn. TMA 2013; 3: 68-74.
Tolibov D.S. Neuropsychological features of Alzheimer's disease. Vestn. TMA 2013; 2: 72-76.
Алексеевич ГЮ, Родиков МВ, Можейко ЕЮ и др. Проблемы когнитивной дисфункции после аорто-коронарного шунтирования. Сибирское медицинское обозрение. 2015;(6):30-6.
Остроумова ОД, Черняева МС, Головина ОВ. Фибрилляция предсердий как фактор риска развития когнитивных нарушений и деменции. Возможности антикоагулянтной терапии в их профилактике. Кардиология. 2018;58(9):76-88.
Парфенов ВА, Старчина ЮА. Когнитивные расстройства и их лечение при артериальной гипертонии. Нервные болезни. 2015; (1):16-22.
Bhamidipati D, Goldhammer JE, Sperling MR, et al. Cognitive Outcomes After Coronary Artery Bypass Grafting. J Cardiothorac Vasc Anesth. 2017 Apr;31(2):707-718.
Fisher TJ, Schwartz AC, Greenspan HN, Heinrich TW. Dementia: A complex disease with multiple etiologies and multiple treatments. Int J Psychiatry Med. 2016;51(2):171-81.
Gorelick PB. Blood Pressure and the Prevention of Cognitive Impairment. JAMA Neurol. 2014 Oct;71(10):1211-3.
Kalantarian S, Stern TA, Mansour M, Ruskin JN. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med. 2013 Mar 5;158(5 Pt 1):338-46.
Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011 Mar 8;76(10):914-22.
Mansur RB, Lee Y, Zhou AJ, et al. Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysis. Ann Clin Psychiatry. 2018 Feb;30(1):38-50.
Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clin Interv Aging. 2014 Jun 28;9:1011-9.
Vincent C, Hall PA. Executive Function in Adults With Type 2 Diabetes: A Meta-Analytic Review. Psychosom Med. 2015 Jul-Aug;77(6): 631-42.
World Health Organization. Dementia: a public health priority. World Health Organization; 2013. 102 p. http://www.who.int/iris/han-dle/10665/112502.
